Substance Use Disorder Market Size to Reach USD 7.7 Million by 2035

According to the IMARC Group, the substance use disorder market size reached a value of USD 5.3 million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 7.7 million by 2035, exhibiting a growth rate (CAGR) of 3.51% during 2025-2035. This can be attributed to an increased usage of behavioral therapies, such as motivational interviewing and cognitive-behavioral therapy (CBT), which assist in recognizing and altering negative thought patterns and behaviors linked to substance abuse. 

Substance use disorder (SUD) is a chronic, relapsing medical disorder that is defined by compulsive drug or alcohol usage. The substance use disorder market is experiencing significant growth, driven by a myriad of factors. Primarily, the rising prevalence of substance use disorders, including the misuse of opioids, alcohol, and other drugs, is fueling market expansion. Furthermore, advancements in pharmacological treatments, such as the development of novel medications like buprenorphine and naltrexone, are providing better management options for patients, thus enhancing market growth. 

Additionally, government initiatives and policies aimed at curbing substance misuse, including funding for medicinal programs and regulatory support for new therapies, are also pivotal in driving the substance use disorder market forward. Concurrently, the healthcare industry's emphasis on comprehensive and holistic therapeutic approaches, which combine medication-assisted treatment (MAT) with behavioral therapies, has proven effective in improving patient outcomes and sustaining market momentum. In addition, R&D activities focusing on understanding the genetic and neurobiological underpinnings of substance use disorders are paving the way for personalized medicine approaches. Apart from this, the involvement of non-profit organizations and advocacy groups in raising awareness and funding research is creating a supportive environment for market expansion. As these trends continue to evolve, the substance use disorder market is poised for sustained expansion, driven by innovations and a growing commitment to addressing such pervasive public health issues.

Request for a sample of this report: https://www.imarcgroup.com/substance-use-disorder-market/requestsample

Countries Covered:

• United States 

• Germany 

• France 

• United Kingdom 

• Italy 

• Spain 

• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario 

• Historical, current, and future performance of the substance use disorder market

• Historical, current, and future performance of various therapeutic categories in the market 

• Sales of various drugs across the substance use disorder market

• Reimbursement scenario in the market 

• In-market and pipeline drugs

This report also provides a detailed analysis of the current substance use disorder market drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview 

• Mechanism of Action 

• Regulatory Status 

• Clinical Trial Results 

• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview 

• Mechanism of action 

• Regulatory status 

• Clinical trial results 

• Drug uptake and market performance

Competitive Landscape with key players:

The competitive landscape of the substance use disorder market has been studied in the report with the detailed profiles of the key players operating in the market.

1. Braeburn
2. Alkermes
3. Indivior
4. Revive Therapeutics
5. atai Life Sciences
6. STALICLA/Novartis
7. Tempero Bio

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145